SAAD ZAFAR: Open Payments
NPI 1275820706 · BECKLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 80 payments from 15 companies in 2025. Trend: 2023 $1,502 · 2024 $1,344 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $349 |
| PFIZER INC. | 26 | $297 |
| Braeburn Inc. | 8 | $159 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $45 |
Products named: NURTEC ODT, VRAYLAR, BRIXADI, REXULTI, QULIPTA, FANAPT, CAPLYTA, COBENFY.
Industry payments across WV — which companies pay providers there.
